Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in own shares executed under the Company's share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 977,325 ordinary shares
- Purchase Date: June 16, 2025
- Highest Price Paid: 393.60 pence per share
- Lowest Price Paid: 388.50 pence per share
- Volume Weighted Average Price: 391.03 pence per share
- Post-Transaction Share Capital: 8,995,585,793 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 8,991,505,588
Material Changes
Following the settlement of the June 16 transaction, the number of ordinary shares with voting rights decreased to 8,991,505,588. This figure is relevant for shareholders determining notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It serves strictly as a regulatory disclosure of a specific share transaction. A full breakdown of individual trades is referenced via an external link to the London Stock Exchange.
Investor Verification Checklist
- Verify the total number of shares repurchased under the Buyback Programme since its inception on March 28, 2025.
- Confirm the remaining authorization limit for the share buyback programme.
- Review the external trade breakdown link provided for granular transaction data.
- Check subsequent filings for updates to the treasury share count and voting share total.